Search results
Former CEO of Aculon and SVP/GM of TaylorMade Golf Joins CEO Coaching International
WJTV Jackson· 5 hours agoAs Chairman & CEO of Aculon, Inc., a Specialty Chemical company, Hughes' visionary leadership transformed the pre-revenue business into a globally respected ...
11 Best Low Price Pharma Stocks To Invest In
Insider Monkey via Yahoo Finance· 2 days agoIn this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want...
Q1 2024 Elevance Health Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoThe collaborative development of the business will advance our enterprise strategy by accelerating the provision of value-based care for our members and consumers more broadly ...
ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound...
Digital Journal· 6 hours agoLONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training ...
Ontrak, Inc. (OTRK) Q4 2023 Earnings Call Transcript
Seeking Alpha· 7 days agoOntrak, Inc. (NASDAQ:NASDAQ:OTRK) Q4 2023 Results Conference Call April 16, 2024 4:30 PM ETCompany ParticipantsRyan Halsted - Investor Relations, Gilmartin...
Ares Takes Fresh Aim at Healthcare Through New Fund
The Wall Street Journal· 6 days agoThe private-credit specialist seeks $1.5 billion to back businesses in sectors such as biotechnology and drugs.
KC Chamber reveals 2024 Top 10 Small Businesses - Kansas City Business Journal
The Business Journals· 4 days agoThe Greater Kansas City Chamber of Commerce revealed its 2024 Top 10 Small Businesses, which range...
Aspen Neuroscience Announces First Patient Dosed in First-in-Human Phase 1/2a Clinical Trial of...
Tehachapi News· 6 days agoAspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open label clinical trial to assess safety and tolerability of ANPD001 ...
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?
The Times of Northwest Indiana· 6 days agoMore than 6 million Americans have Alzheimer’s disease, the most common cause of dementia. There’s...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 12 hours agoElectroceuticals/Bioelectric Medicine Market to Reach $40.5 Billion, Globally, by 2032 at 7.4% CAGR: Allied Market Research PR Newswire PORTLAND, Ore., April 23, 2024 Increasing prevalence of chronic diseases, advancements in technology, and rising
